Product image
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
February 21, 2024 08:00 ET | Route 92 Medical, Inc.
Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.
22157.jpg
Stroke Rehabilitation Industry Poised for Growth as Innovations in Virtual Reality and Tele-Rehabilitation Advance
January 31, 2024 10:33 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Stroke Rehabilitation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
22157.jpg
Stroke Management Market Poised to Surge from $36.94 Billion to $39.98 Billion in 2024
January 28, 2024 19:56 ET | Research and Markets
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Stroke Management Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global landscape of stroke management...
R-Rt92-logo-rbg0.png
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
November 16, 2023 09:00 ET | Route 92 Medical, Inc.
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.
R-Rt92-logo-rbg0.png
Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
November 14, 2023 09:00 ET | Route 92 Medical, Inc.
Multicenter clinical study results published in Stroke: Vascular and Interventional Neurology show benefits of Route 92 Medical's Tenzing technology.
Emergen logo.png
Global Urgent Care Apps Market Size USD 42,960.91 Million in 2032 | Emergen Research
November 07, 2023 14:00 ET | Emergen Research
Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global urgent care apps market is projected to reach value of USD 42,960.91 Million by 2032, according to a current analysis by Emergen Research....
22157.jpg
Neurovascular Devices Market - Global Forecast to 2028: Increasing Incidence of Ischemic Stroke and Cerebral Aneurysms Boosts Demand
October 18, 2023 05:48 ET | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters),...
EC-Logo-2018_TM_CMYK.jpg
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
October 10, 2023 08:00 ET | electroCore, Inc.
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache Associated with Subarachnoid Hemorrhage (SAH) “NOVIS” Clinical Trial (n=150) of nVNS for the...
Aviv-Clinic Logo.png
Aviv Clinics Highlights Case Report Showing Hyperbaric Oxygen Therapy Improves Post-Stroke Rehabilitation, Specifically Hand Motor Recovery
October 02, 2023 13:04 ET | Aviv Clinics
ORLANDO, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the world’s most advanced brain clinics, shares the results of a new case report showing a unique hyperbaric oxygen therapy...
Company logo.png
A Special Protocol Assessment Agreement Reached with the U.S. Food and Drug Administration for Phase 3 clinical trial of Sovateltide for the treatment of acute cerebral ischemic stroke patients
October 02, 2023 07:25 ET | Pharmazz, Inc.
Special Protocol Assessment Agreement Reached Between Pharmazz, Inc. and the U.S. Food and Drug Administration for Phase 3 Clinical Trial of Sovateltide